Fewer companies are doing AIDS drugs research today than were in 1997, which is significant because breakthroughs are constantly and urgently required, and resistance to existing drugs is surging.

Abstract

Increased donated and subsidised medicines for malaria are saving countless lives in Africa, but there is probably increasing theft and diversion of those medicines. The impact of medicine diversion is unknown but potentially dangerous and may bolster criminal networks and increase medicine stock outs (1,2). This study demonstrates...

"Phake: The Deadly World of Falsified and Substandard Medicines" explores the underground trade in illegal medicines that kills over 100,000 people per year and supplants billions of dollars of real products.

It is time for a thorough investigation of drug theft at the Global Fund to ensure that drugs are being used by those intended, rather than encouraging illegal parallel distribution systems, in both recipient nations and nations where products are diverted.

The malaria community has done a great job over the past decade to combat the disease. But this may be about to change.

Online registration for this event is now closed. Walk-in registrations will be accepted.

Even though more and more people worldwide are gaining access to AIDS treatment, there has been an apparent decline in the number of companies investing in HIV/AIDS. Why? Could it be that recent policy decisions by the World...

Leadership is a wonderful thing, but it is truly found when it is tested, and on that count malaria leadership has failed.

There is a lack of incentives driving agencies to actively address the problem of counterfeit medicine--some individuals may care enough to risk their jobs by speaking out, but most keep their mouths shut.